Validation of Chinese SRI Questionnaire

Guangzhou Institute of Respiratory Disease150 enrolled

Overview

Assessment of health-related quality of life in COPD patients with severe chronic respiratory failure requires appropriate and highly specific measurement tools. We attempt to validate the Chinese version of the Severe Respiratory Insufficiency Questionnaire (SRI)

Study Type

OBSERVATIONAL

Enrollment

150

Conditions

Chronic Obstructive Pulmonary Disease Hypercapnic Respiratory Failure

Eligibility

Sex: ALLMin age: 18 YearsMax age: 80 Years

Medical Language ↔ Plain English

Inclusion Criteria: 1. Adult COPD Patients with chronic hypercapnic respiratory failure established on home noninvasive ventilation for at least 1 month 2. Patients are in a clinically stable state,without any changes of medication during the previous 4 weeks. Exclusion Criteria: 1. patient's refusal to participate 2. Patients with evidence of acute respiratory failure i.e.patients with worsening of symptoms during the previous 2 weeks, a pH ,7.35, or with signs of respiratory infection

Locations (1)

Guangzhou Institute of Respiratory Disease

Guangzhou, Guangdong, China

RECRUITING

Outcomes

Primary Outcomes

Reliability of Severe Respiratory Insufficiency Questionnaire

Time frame: 2 weeks

Secondary Outcomes

Construct validity of Severe Respiratory Insufficiency Questionnaire

Time frame: 2 weeks

Criterion validity of Severe Respiratory Insufficiency Questionnaire

Time frame: 2 weeks

Central Contacts

Zhou LuQian, Doctor

CONTACT

+86-15622236759 zhlx09@163.com

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.